Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphosys Ag ADR (NQ: MOR )

3.890 -0.100 (-2.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 463,395
Open 3.940
Bid (Size) 1.560 (2)
Ask (Size) 4.620 (1)
Prev. Close 3.990
Today's Range 3.870 - 3.980
52wk Range 3.170 - 7.450
Shares Outstanding 32,890,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From MorphoSys AG
Via Business Wire
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga

Performance

YTD
+9.42%
+9.42%
1 Month
-15.62%
-15.62%
3 Month
+12.43%
+12.43%
6 Month
-20.61%
-20.61%
1 Year
-45.44%
-45.44%

More News

Read More
MorphoSys's Earnings Outlook
Via Benzinga
Invitation to MorphoSys' Full Year Results 2022 Conference Call on March 16, 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
MorphoSys Stops Work and Operations on Pre-Clinical Research Programs
Via ACCESSWIRE
Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
Via ACCESSWIRE
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
Via Benzinga
MorphoSys AG: Financial Calendar 2023
Via ACCESSWIRE
MorphoSys Earnings Preview
Via Benzinga
MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
Via ACCESSWIRE
MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
MorphoSys Inks Licensing Agreement With Novartis For Preclinical Cancer Programs
Via Benzinga
Is The Oil And Gas Bull Market Over? This 2X Leveraged ETF Inversely Tracks Exxon, Occidental And More
Via Benzinga
MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results
From MorphoSys AG
Via Business Wire
Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Scheduled For November 16, 2022
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.